title: The impact of molecular medicine upon early cardiovascular drug development.
authors.affiliation: Cardiovascular Clinical Pharmacology, Division of Clinical Pharmacology, Glaxo Wellcome R & D, Greenford, Middlesex. MWL12467@glaxowellcome.co.uk
authors.forename: M W
authors.initials: MW
authors.lastname: Lunnon
authors.forename: M
authors.initials: M
authors.lastname: Braddock
mesh_terms: D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D015316:Genetic Therapy; D006801:Humans; D008967:Molecular Biology; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use
chemical_list: D002317:Cardiovascular Agents; D016376:Oligonucleotides, Antisense